
Job description
We are seeking a Senior Director of Health Economics and Outcomes Research / Real World Evidence to join the IDEAYA Commercial team. The Senior Director, HEOR/RWE will be responsible for shaping and executing IDEAYA’s health economics, outcomes research, and real-world evidence strategy for the launch of darovasertib in metastatic uveal melanoma (mUM).
Develop and execute the HEOR and RWE strategy to support US value demonstration for darovasertib at launch and through its lifecycle. Collaborate with Market Access, Medical Affairs and Clinical Development to evaluate data gaps and develop robust evidence generation and publication plans.
This leader will play a pivotal role in generating evidence in a very high unmet disease area for payers, providers, and patients. They will have an opportunity to take innovative approaches to value demonstration in orphan diseases, biomarker-driven populations, and unique combination treatments.
Company

Healthcare
IDEAYA Biosciences is an oncology-focused precision medicine company headquartered in South San Francisco, California. The company specializes in discovering and developing targeted therapeutics for patient populations defined by molecular diagnostics, with a primary emphasis on synthetic lethality—a cutting-edge class of precision medicine targets. By pursuing first-in-class and best-in-class agents, IDEAYA aims to deliver innovative, highly selective treatments that address unmet needs in cancer care. Its integrated approach combines advanced genomic profiling with rigorous preclinical and clinical development, positioning IDEAYA as a leader in the evolving field of precision oncology.
Keep exploring

IDEAYA Biosciences

Ultragenyx

IDEAYA Biosciences

IDEAYA Biosciences
GSK
Revolution Medicines